Elicio Therapeutics, Inc. Common Stock (ELTX) Stock Price

ELTXStock

$3.01−74.75%52W

Market Cap$79.11M

P/E—

PEG Ratio—

Div yield—

Beta1.31

ELTX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-77.69%

Price vs S&P 500 (4W)-2.04%

VGM Score6.87

Book Value / Share (Quarterly)$0.09

P/TBV (Annual)1.15x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-2.07

Price vs S&P 500 (YTD)-74.52%

Gross Margin (TTM)98.48%

Net Profit Margin (TTM)-81.45%

EPS (TTM)$-2.41

10-Day Avg Trading Volume0.25M

EPS Excl Extra (TTM)$-2.41

EPS (Annual)$-4.33

ROI (Annual)-309.46%

Gross Margin (Annual)100.00%

Net Profit Margin (5Y Avg)-1577.53%

Cash / Share (Quarterly)$0.80

ROA (Last FY)-184.54%

Revenue Growth TTM (YoY)-91.88%

EBITD / Share (TTM)$-2.25

Operating Margin (TTM)-83.03%

Cash Flow / Share (Annual)$-2.08

P/B Ratio45.18x

P/B Ratio (Quarterly)85.10x

Net Income / Employee (Annual)$-1,575,800

Net Interest Coverage (TTM)-663.06x

ROA (TTM)-151.12%

EPS Incl Extra (Annual)$-4.33

Current Ratio (Annual)2.38x

Quick Ratio (Quarterly)2.07x

3-Month Avg Trading Volume1.24M

52-Week Price Return-74.75%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$1.59

P/S Ratio (Annual)32.14x

Asset Turnover (Annual)0.04x

52-Week High$16.00

Operating Margin (5Y Avg)-1344.62%

EPS Excl Extra (Annual)$-4.33

CapEx CAGR (5Y)-16.74%

26-Week Price Return-66.44%

Quick Ratio (Annual)2.29x

13-Week Price Return-69.90%

Total Debt / Equity (Annual)5.75x

Current Ratio (Quarterly)2.24x

Enterprise Value$68.45M

Asset Turnover (TTM)0.33x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-1687.39%

Cash / Share (Annual)$1.04

3-Month Return Std Dev249.53%

Gross Margin (5Y Avg)80.96%

Net Income / Employee (TTM)$-1,217,700

ROE (Last FY)-309.46%

Net Interest Coverage (Annual)-62.99x

EPS Basic Excl Extra (Annual)$-4.33

Total Debt / Equity (Quarterly)5.75x

EPS Incl Extra (TTM)$-2.41

Receivables Turnover (Annual)5.71x

ROI (TTM)-354.47%

P/S Ratio (TTM)2.49x

Pretax Margin (5Y Avg)-1577.53%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$14.54

Price vs S&P 500 (52W)-93.06%

Year-to-Date Return-62.56%

5-Day Price Return-4.18%

EPS Normalized (Annual)$-4.33

ROA (5Y Avg)-122.69%

Net Profit Margin (Annual)-1687.39%

Month-to-Date Return6.43%

Cash Flow / Share (TTM)$-7.66

EBITD / Share (Annual)$-3.72

Operating Margin (Annual)-1722.61%

LT Debt / Equity (Annual)5.75x

LT Debt / Equity (Quarterly)5.75x

EPS Basic Excl Extra (TTM)$-2.41

P/TBV (Quarterly)3.80x

P/B Ratio (Annual)85.10x

Pretax Margin (TTM)-81.45%

Book Value / Share (Annual)$0.09

Price vs S&P 500 (13W)-72.69%

Beta1.31x

Revenue / Share (TTM)$0.00

ROE (TTM)-977.67%

52-Week Low$2.66

gGradeF

mGradeF

vgmGradeF

ELTX Earnings Surprise History

Q2 25-0.66est. -0.69

Q3 25-0.60est. -0.48

Q4 25-0.49est. -0.45

Q1 26-0.65est. -0.47

Q2 26-0.43est. -0.54

ELTX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

4.10

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
ELTXElicio Therapeutics, Inc. Common Stock	—	F	F	$3.01
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Elicio Therapeutics, Inc. Common Stock

Elicio Therapeutics is a clinical-stage biotechnology company developing cancer immunotherapies using its proprietary Amphiphile (AMP) platform, which delivers treatments directly to lymph nodes. The company targets biologically validated but traditionally hard-to-drug cancer targets for patients with limited treatment options.